Applying this approach to a cohort of patients with suspected PIDD led to the identification of novel hyperactivating JAK1 variants and expanded the clinical spectrum of JAK1 GOF-associated disease to include autoimmunity and susceptibility to infections (Philips et al, 2022). The gene discussed is JAK1; the disease is Autoimmunity.